HCRT and obesity disorder: The extraordinary sample distribution of orexin A in our COVID-19 cohort was not dependent on sex, age, BMI, glucose, insulin, cardiovascular disease, obesity, or diabetes mellitus (Supplementary Figs 1 and 2).